Perianal Crohn disease: Evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity

Radiology

Volumn 251, Issue 2, 2009, Pages 380-387

  Horsthuis, Karin ^a   Lavini, Cristina ^a   Bipat, Shandra ^a   Stokkers, Pieter C F ^a   Stoker, Jaap ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADODIAMIDE; GADOLINIUM PENTETATE;

ADULT; ANUS FISTULA; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE ACTIVITY; EVALUATION; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PERIANAL DISEASE ACTIVITY INDEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; ADOLESCENT; ANUS DISEASE; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; ANUS DISEASES; CONTRAST MEDIA; CROHN DISEASE; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 66149103650     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2512072128     Document Type: Article

References (21)

1. American Gastroenterological Association Clinical Practice Committee. American Gastroenterological Association medical position statement: perianal Crohn's disease. Gastroenterology 2003;125:1503-1507. (Pubitemid 37409771)
2. Caprilli R, Gassull MA, Escher JC, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006;55(suppl 1):i36-i58. (Pubitemid 43268292)
3. Sahni VA, Ahmad R, Burling D. Which method is best for imaging of perianal fistula? Abdom Imaging 2008;33:26-30.
4. Spencer JA, Ward J, Beckingham IJ, Adams C, Ambrose NS. Dynamic contrast-enhanced MR imaging of perianal fistulas. AJR Am J Roentgenol 1996;167:735-741. (Pubitemid 26279727)
5. Halligan S, Stoker J. Imaging of fistula in ano. Radiology 2006;239:18-33.
6. Weinmann HJ, Brasch RC, Press WR, Wesbye GE. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol 1984;142:619-624. (Pubitemid 14199123)
7. Brahme F, Lindstrom C. A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn's disease and in ulcerative colitis. Gut 1970;11:928-940.
8. van Dijke CF, Peterfy CG, Brasch RC, et al. MR imaging of the arthritic rabbit knee joint using albumin-(Gd-DTPA)30 with correlation to histopathology. Magn Reson Imaging 1999;17:237-245.
9. Van Assche G, Vanbeckevoort D, Bielen D, et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am J Gastroenterol 2003;98:332-339.
10. Lavini C, De Jonge MC, van de Sande MG, Tak PP, Nederveen AJ, Maas M. Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. Magn Reson Imaging 2007;25:604-612. (Pubitemid 46817804)
11. van Rijswijk CS, Geirnaerdt MJ, Hogendoorn PC, et al. Soft-tissue tumors: value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy. Radiology 2004;233:493-502.
12. Hayes C, Padhani AR, Leach MO. Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002;15:154-163. (Pubitemid 34213405)
13. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med 1991;17:357-367.
14. Irvine EJ; McMaster IBD Study Group. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. J Clin Gastroenterol 1995;20:27-32.
15. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-1405.
16. Zou KH, Tuncali K, Silverman SG. Correlation and simple linear regression. Radiology 2003;227:617-622. (Pubitemid 36583011)
17. Danese S, Sans M, de la Motte C, et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006;130:2060-2073.
18. Tamai K, Yamato M, Yamaguchi T, Ohno W. Dynamic magnetic resonance imaging for the evaluation of synovitis in patients with rheumatoid arthritis. Arthritis Rheum 1994;37:1151-1157. (Pubitemid 24313314)
19. Østergaard M, Stoltenberg M, Løvgreen-Nielsen P, Volck B, Sonne-Holm S, Lorenzen I. Quantification of synovitis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn Reson Imaging 1998;16:743-754.
20. Florie J, Wasser MN, Arts-Cieslik K, Akkerman EM, Siersema PD, Stoker J. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. AJR Am J Roentgenol 2006;186:1384-1392. (Pubitemid 46112577)
21. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002;122:512-530.